| Homozygous variant of antithrombin with lack of affinity for heparin: management of severe thrombotic complications associated with intrauterine fetal demise. | |
| | |
MedLine Citation:
|
PMID: 8958394 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Patients with homozygous heparin-binding-site (HBS) qualitative antithrombin deficiencies are at significant risk of venous and arterial thrombosis. We report on the eighth case of homozygous HBS deficiency, and the fourth case concerning the Arg 47-Cys mutation. The proposita is a 25 year old, without known thrombotic antecedent, despite an oral contraceptive therapy for 7 years. After 25 weeks of a first pregnancy, she presented an intrauterine fetal demise complicated with deep vein thrombosis and pulmonary embolism. Heparin therapy was inefficient (no clinical nor angiographic improvement, no biological hypocoagulability). Heparin cofactor activity was < 10%, antigen concentration was normal. The crossed immunoelectrophoresis of patient's plasma, with and without heparin, showed a typical profile of qualitative HBS antithrombin deficiency. The molecular analysis revealed an homozygous Arg 4-Cys mutation. Antithrombotic therapy was achieved with continuous infusion of antithrombin concentrates (80 IU/kg/day) and unfractionated heparin (500 IU/kg/day) during 12 days, leading to clinical improvement, and followed by treatment with vitamin K antagonists. This observation emphasizes the risk of intrauterine fetal demise and the inefficiency of heparin therapy without antithrombin infusion in type II HBS homozygous deficiency. The management of a future pregnancy will probably require repeated infusions of antithrombin. |
| | |
Authors:
|
A Bauters; C Zawadzki; A Bura; C Théry; A Watel; D Subtil; M Aiach; J Emmerich; B Jude |
Related Documents
:
|
12521884 - Pregnancy outcome in women with prosthetic heart valves. 22475694 - The role of preterm placental calcification in high-risk pregnancy as a predictor of po... 2121034 - Emergency treatment with recombinant tissue plasminogen activator of pulmonary embolism... 18042774 - Anticoagulation for prosthetic heart valves in pregnancy. is there an answer? 18295184 - Effects of navigation method on workload and performance in simulated high-speed ship n... 2555254 - The p-m and the 23.5 mrf (hobo) systems of hybrid dysgenesis in drosophila melanogaster... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Volume: 7 ISSN: 0957-5235 ISO Abbreviation: Blood Coagul. Fibrinolysis Publication Date: 1996 Oct |
Date Detail:
|
Created Date: 1997-02-26 Completed Date: 1997-02-26 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9102551 Medline TA: Blood Coagul Fibrinolysis Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 705-10 Citation Subset: IM |
Affiliation:
|
Laboratoire d'Hematologie A, Hôpital Cardiologique, Lille, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antithrombin III / genetics*, metabolism Binding Sites / genetics Blood Coagulation Factors / analysis Female Fetal Death* Heparin / metabolism*, therapeutic use Homozygote* Humans Immunoelectrophoresis, Two-Dimensional Pregnancy Pregnancy Complications, Hematologic / blood* Sequence Analysis, DNA Thrombosis / blood*, drug therapy, genetics* |
| Chemical | |
Reg. No./Substance:
|
0/Blood Coagulation Factors; 9000-94-6/Antithrombin III; 9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Activated protein C resistance in patients with anti-beta 2 glycoprotein I antibodies.
Next Document: Medicine and the Internet: dreams, nightmares and reality.